Background: Renal cell carcinoma (RCC) is common renal malignancy within poor prognosis. Histone methylase SET8 plays vital roles in tumorigenesis through regulating Wnt/ β-catenin signaling and other cancer-related pathways. Here, we studied the expression and function of SET8 inccRCC Methods: Our study was performed immunohistochemistry to assess the overall levels of SET8 and β-catenin in a tissue microarray with 50 RCC specimens. Then, we examined the protein levels of SET8 in RCC and reduced the expression of SET8 by shRNA-mediated partial depletion in order to systematically investigate whether SET8 was involved inRCC carcinogenesis and tumor development measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, trans well assay and flow cytometry, respectively. Protein and mRNA expression were assayed by western blotting and quantitative real-time PCR (qPCR). The association between proteins was assayed by co-immunoprecipitation. Results: SET8 levels and the abnormal expression of β-catenin in the diverse RCC subtypes were inversely correlated with Fuhrman grading, pT stage, and metastasis. Further, shRNA-mediated partial depletion of SET8 reduced 786-0 and ACHN cell viability, arrested them at S phase of the cell cycle and inhibited their abilities of invasion and metastasis. Moreover, western blot implied that several protein expressions of Wnt target genes were inhibited by SET8 interference. It was found that SET8 directly interacted with lymphoid enhancing factor-1 (LEF1)/TCF4, and regulated the transcription of Wnt-activated genes, possibly through H4K20monomethylation at the target gene promoters. Conclusions: Collectively, these results suggested that SET8 could serve as a promising biomarker and contribute to predicting distal metastasis and prognosis of patient with RCC. Cite this abstract as: Shen T, Yi X, Zhou W. The positive expression of SET8 possesses prognostic relevance and mediates Wnt target gene activation in renal cell carcinoma.
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Background: Renal cell carcinoma (RCC) is common renal malignancy within poor prognosis. Histone methylase SET8 plays vital roles in tumorigenesis through regulating Wnt/ β-catenin signaling and other cancer-related pathways. Here, we studied the expression and function of SET8 inccRCC Methods: Our study was performed immunohistochemistry to assess the overall levels of SET8 and β-catenin in a tissue microarray with 50 RCC specimens. Then, we examined the protein levels of SET8 in RCC and reduced the expression of SET8 by shRNA-mediated partial depletion in order to systematically investigate whether SET8 was involved inRCC carcinogenesis and tumor development measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, trans well assay and flow cytometry, respectively. Protein and mRNA expression were assayed by western blotting and quantitative real-time PCR (qPCR). The association between proteins was assayed by co-immunoprecipitation. Results: SET8 levels and the abnormal expression of β-catenin in the diverse RCC subtypes were inversely correlated with Fuhrman grading, pT stage, and metastasis. Further, shRNA-mediated partial depletion of SET8 reduced 786-0 and ACHN cell viability, arrested them at S phase of the cell cycle and inhibited their abilities of invasion and metastasis. Moreover, western blot implied that several protein expressions of Wnt target genes were inhibited by SET8 interference. It was found that SET8 directly interacted with lymphoid enhancing factor-1 (LEF1)/TCF4, and regulated the transcription of Wnt-activated genes, possibly through H4K20monomethylation at the target gene promoters. Conclusions: Collectively, these results suggested that SET8 could serve as a promising biomarker and contribute to predicting distal metastasis and prognosis of patient with RCC. AB253. The time-dependent changes of the testicular weight and vascular endothelial growth factor expression in cryptorchidism mouse model at different day intervals
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Background: The present research details the expression of vascular endothelial growth factor (VEGF) and pathological changes of testis in cryptorchidism model. We also tried to find relationship between VEGF and pathological changes in cryptorchidism. Methods: Six-week-old ICR male mice were operated to induce unilaterally cryptorchid model. The expression o f V E G F w a s i n v e s t i g a t e d b y We s t e r n b l o t a n d Immunohistochemistry. Hematoxylin-eosin staining was used to evaluate pathological changes at different day intervals. Results: In our study, immunohistochemistry of VEGF in testicular cross sections suggested that the VEGF was expressed in the cytoplasm of leydigcells, Sertoli cells and germ cells. Quantitative analysis of VEGF by Western blot showed a time-dependent decrease of VEGF expression in cryptorchidism. VEGF expression significantly decreased at day 7, the lowest at day 21 and then little recovery was observed at day 28 in unilateral cryptorchid testis. Conclusions: Interestingly, the expression of VEGF was decreased significantly at day 14, the lowest at day 21 and then little recovery was observed at day 28 in its self-control testis. The decreased and recovered weight of testis was similar to VEGF expression in unilateral cryptorchid testis and self-control testis. Therefore, we propose that there is a time dependent decrease of VEGF expression in cryptorchidism. VEGF have an important role on impaired spermatogenesis in cryptorchidism. Background: Autophagy serves as a catabolic pathway to maintain cellular homeostasis. The role of autophagy in cancer cells is essential for supplying adequate substrates for proliferation and metabolism. Recent study identified DU145, different from LNCaP and PC-3 cells, was an autophagy-deficient cell line due to the deficiency of ATG5 protein. However, ATG5-independent alternative macroautophagy has already been discovered in ATG5 knockout mouse embryo fibroblasts. In this study, our goal is to discover whether DU145 is a naturally occurring cell with such an alternative autophagy. Methods: The lipidation levels of microtubule-associated protein 1 light chain 3 (LC3) was detected by Western blotting. Cultured cells were transfected with the GFP-LC3 expressing plasmid and the fluorescence was viewed using confocal microscopy. Ultrastructure was observed using transmission electron microscopy. Immuno-electron microscopy was performed to determine the co-location of LC3 and autophagic vacuoles. Results: Under basal condition, the lipidation form of LC3, known as LC3-II, is detectable in both PC-3 and LNCaP cells. Stimulating autophagy with rapamycin or blocking autophagosome degradation with chloroquine increased the LC3-II levels in these cell lines. In contrast, LC3-II is constitutively undetectable in DU145 cells even treated with rapamycin or chloroquine. Similarly, the formation of autophagosome indicated by GFP-LC3 punctate was not easily observed in DU145 treated with rapamycin or chloroquine. Interestingly, we observed a great number of intracellular autophagic vacuoles under electron microscopy in all of three cell lines after starvation. Immuno-electron microscopy was applied with primary antibodies against LC3. Autophagic vacuoles labeled well with antibody against LC3-II in both PC-3 and LNCaP cells, rather than DU145 cells. These results suggested that DU145 is a naturally occurring cell with ATG5-independent autophagy. Conclusions: Our findings reveal that DU145 is a naturally occurring cell with an ATG5-independent alternative autophagy, which indicates a novel category of tumor cells may exists in prostate cancer patients. 
